FdaApplication
NDA 209830
Identifiers
- fda_app_no: NDA209830
Properties
| Property | Value |
|---|---|
| applicant_name | ALKERMES INC |
| application_type | NDA |
| approval_date | 2018-06-29 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ARISTADA INITIO KIT | ARIPIPRAZOLE LAUROXIL | 675MG/2.4ML (281.25MG/ML) | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR |
1 product